Similarly, a mutation in FOXP3 gene is associated with spontaneous development of inflammatory bowel disease (IBD) (26) and a phase 1 clinical trial of Treg therapy in patients with refractory Crohn's disease was found to be effective (51). Here, FOXP3 is linked to inflammatory bowel disease.